The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,329 records6 sources
Showing 553–576 of 11,329
Trial

Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.

ClinicalTrials.gov2026
Trial

Effect of Opioid-Sparing Anesthesia on Postoperative Opioid Consumption and Pain in Elderly Patients Undergoing Spine Surgery

ClinicalTrials.gov2026
PreregistrationKetamine

Ketamine combined with structured psychological therapy for chronic pain with comorbid depression

OSF2026
TrialPsilocybin

Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

ClinicalTrials.gov2026
ArticleDMT

Pharmacokinetics, pharmacodynamics and safety of <i>N,N</i>-dimethyltryptamine administered intravenously in healthy smoking and non-smoking volunteers.

van der Heijden KV, Makai-Bölöni S, Inamdar A +9

Europe PMC2026
ArticleLSD

A Stereoconvergent Annulation in the Synthesis of Lysergic Acid.

Firestone ZD, Harbit RC, Smith JM

Europe PMC2026
PreprintPsychedelics

A Multidisciplinary Therapeutic Framework for Neuropsychiatric, Neurological and Functional Disorders, Encompassing Psychedelic, Pharmaceutical, Botanical and Nutraceutical Interventions, Delivery Systems and Lifestyle Modifications

Kaufman RC

Europe PMC2026
ArticleKetamine

Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).

Llorca PM, Sauvaget A, Olié E +12

Europe PMC2026
ArticleKetamine

Paediatric Ketamine Bladder Case Report: A Burgeoning Problem in the Paediatric Population.

Kulkarni S, Visa A, Isaac M +5

Europe PMC2026
ArticleKetamine

The role of ventral tegmental area dopamine neurons in emergence from dexmedetomidine, fentanyl, and ketamine anesthesia in rats.

Obert DP, Obert DP, Vincent KF +7

Europe PMC2026
ArticleKetamine

Consent beyond the written form: Implications for ketamine trials in the Philippines.

Pagallaman AA, Fermin JNE

Europe PMC2026
TrialPsilocybin

The Effects of Psilocybin on Social Connectedness

ClinicalTrials.gov2026
PreprintMDMA

Beyond the empathogen label: the social-affective profile of MDMA

Weeda M, Gazzola V, Smith M +3

Europe PMC2026
PreprintPsychedelics

Melodic Modulation of Pain and Cognition: Neurobehavioral Effects of Indian Classical Music in Mice

Mukherjee K, Bhattacharya T, Parvage S +5

Europe PMC2026
ArticlePsychedelics

Psychedelic renaissance in healthcare: between the biomedical and the existential.

Laforest D

Europe PMC2026
ArticlePsilocybin

Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.

Lovell TN, James PB, Hodgins SL +3

Europe PMC2026
ArticleKetamine

An integrative model of ketamine-induced memory dysfunction: From synapse to circuit in clinical context.

Mohammadi M, Saeedi A, Vakilabad AAK +3

Europe PMC2026
ArticlePsychedelics

Hippocampal synaptic transmission and Ca<sup>2</sup>⁺ signaling are altered by the selective 5-HT<sub>2A</sub> receptor agonist, 25CN-NBOH.

Wang Y, Karaca SC, Rasmussen MD +2

Europe PMC2026
ArticlePsilocybin

A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.

Tai ML, Szigeti B, Downey AE +12

Europe PMC2026
ArticleKetamine

Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.

Martiadis V, Raffone F, Atripaldi D +8

Europe PMC2026
ArticleKetamine

Correction: Esketamine-led opioid-free anaesthesia reduces postoperative pulmonary complications in bariatric surgery patients: a prospective randomized controlled trial.

Sun HL, Liu HY, Jiang CQ +7

Europe PMC2026
ArticleKetamine

The role of BDNF promoter VI in mediating protective effects of prophylactic (R,S)-ketamine.

Chen BK, Williams BL, Darling A +3

Europe PMC2026
ArticlePsilocybin

Oncology Providers' Perspectives on Psychedelic-Assisted Therapy.

Hanubal KS, Munjal AN, Park J +6

Europe PMC2026
ArticlePsilocybin

Nursing education for emerging psychedelic-assisted therapy: A role-calibrated curriculum approach.

Yıldız E

Europe PMC2026